Stakeholder Perspectives on the Integration of AI in Diabetes Care: Systematic Review of Qualitative Studies.
Héctor Martínez-Martínez, Julia Martínez-Alfonso, Belén Sánchez-Rojo-Huertas et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review synthesized qualitative studies on stakeholder perspectives regarding AI integration in diabetes care, involving 738 participants across 9 countries. Stakeholders recognized AI's potential to enhance individualized care and decision-making but expressed concerns about accuracy, bias, and the impact on human-centered care. Eleven findings were rated as high confidence.
Key findings
- Stakeholders identified AI's potential to support preventive and individualized care in diabetes management.
- Concerns included accuracy, bias, privacy, and increased caregiver workload.
- Participants emphasized the need for explainability and integration with existing systems.
- Eleven findings were rated as high confidence regarding stakeholder perceptions.
Why it matters
Understanding stakeholder perspectives on AI in diabetes care is crucial for developing effective tools that enhance patient management while addressing concerns about safety, privacy, and the human element in care.
What to keep in mind
Evidence was limited by heterogeneity in AI modalities, stakeholder groups, and technology exposure, as well as demographic imbalance.